Advertisement

Topics

Merck KGaA Keen To Remain Key Player In MS Now And In Future

05:58 EDT 14 May 2019 | SCRIP

The German company is predicting sales in mid-triple-digits in 2019 for Mavenclad, its multiple sclerosis drug which has just been...

      

Related Stories

 

Original Article: Merck KGaA Keen To Remain Key Player In MS Now And In Future

NEXT ARTICLE

More From BioPortfolio on "Merck KGaA Keen To Remain Key Player In MS Now And In Future"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...